Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) — Cash Flow Reinvestment Rate
Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) has a Cash Flow Reinvestment Rate of 0.93x as of September 2025, reinvesting CN¥82.19 Million (capex CN¥82.19 Million ) from operating cash flow of CN¥88.00 Million. Check earnings quality score of Guangdong Zhongsheng Pharmaceutical Co L to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Guangdong Zhongsheng Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2006–2024)
Historical reinvestment intensity for Guangdong Zhongsheng Pharmaceutical Co Ltd across 19 annual periods. Explore 002317 long-term investments to assets to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Guangdong Zhongsheng Pharmaceutical Co Ltd (2006–2024)
Year-by-year capital reinvestment analysis for Guangdong Zhongsheng Pharmaceutical Co Ltd. For live market cap and broader valuation context, see 002317 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.49x | CN¥841.02 Million | CN¥337.84 Million | CN¥228.26 Million | ▼ -57.1% |
| 2023 | 5.80x | CN¥1.11 Billion | CN¥190.61 Million | CN¥363.06 Million | ▼ -33.1% |
| 2022 | 8.67x | CN¥547.02 Million | CN¥63.07 Million | CN¥267.96 Million | ▲ +681.6% |
| 2021 | 1.11x | CN¥691.07 Million | CN¥622.77 Million | CN¥213.76 Million | ▼ -47.2% |
| 2020 | 2.10x | CN¥291.87 Million | CN¥138.93 Million | CN¥154.43 Million | ▲ +100.4% |
| 2019 | 1.05x | CN¥263.23 Million | CN¥251.16 Million | CN¥128.33 Million | ▼ -3.4% |
| 2018 | 1.08x | CN¥354.39 Million | CN¥326.78 Million | CN¥143.48 Million | ▼ -29.3% |
| 2017 | 1.53x | CN¥567.68 Million | CN¥369.91 Million | CN¥124.28 Million | ▼ -38.1% |
| 2016 | 2.48x | CN¥838.45 Million | CN¥338.28 Million | CN¥141.19 Million | ▼ -12.1% |
| 2015 | 2.82x | CN¥542.27 Million | CN¥192.25 Million | CN¥76.57 Million | ▲ +42.2% |
| 2014 | 1.98x | CN¥199.54 Million | CN¥100.60 Million | CN¥199.54 Million | ▲ +96.7% |
| 2013 | 1.01x | CN¥111.91 Million | CN¥110.95 Million | CN¥111.91 Million | ▲ +85.5% |
| 2012 | 0.54x | CN¥77.42 Million | CN¥142.38 Million | CN¥77.42 Million | ▼ -79.3% |
| 2011 | 2.63x | CN¥185.41 Million | CN¥70.56 Million | CN¥185.41 Million | ▲ +259.6% |
| 2010 | 0.73x | CN¥67.02 Million | CN¥91.72 Million | CN¥67.02 Million | ▲ +222.9% |
| 2009 | 0.23x | CN¥22.83 Million | CN¥100.89 Million | CN¥22.83 Million | ▼ -15.4% |
| 2008 | 0.27x | CN¥19.49 Million | CN¥72.86 Million | CN¥19.49 Million | ▼ -48.6% |
| 2007 | 0.52x | CN¥25.67 Million | CN¥49.35 Million | CN¥25.67 Million | ▼ -5.4% |
| 2006 | 0.55x | CN¥9.84 Million | CN¥17.91 Million | CN¥9.84 Million | — |